There is no validated PHQ-2 or PHQ-9 depression instrument or explicit mental-health question, no dedicated eating-disorder screen, no substance or alcohol screen, no structured allergy capture, and no broader comorbidity multi-select covering hypertension, sleep apnea, NAFLD, PCOS, or GERD
When will I observe therapeutic effects from Thymalin
Helicobacter pylori induced apoptosis
Visceral fat itself is an inflammatory tissue, and reducing it through peptide therapy can decrease systemic inflammation markers
For context, weekly semaglutide produced ~15% placebo-adjusted weight loss at 68 weeks in STEP 1, weekly tirzepatide produced ~21% at 72 weeks in SURMOUNT-1, and retatrutide hit 28.7% at 68 weeks in TRIUMPH-4